MedTrace Logo

Better Life by Nutrition During Adulthood

NCT02899416 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 72

Last updated 2025-12-23

No results posted yet for this study

Summary

BELINDA is a follow'up of subjects included 10 years ago in HELENA study which was a cross-sectional study carried out from 2006 to 2007 in more than 3500 adolescents aged from 12.5 to 17.5 years old through 10 Europeans towns from 9 countries.

BELINDA main objective is to assess CV risk using PDAY score (Pathobiological Determinants of Atherosclerosis in Youth) during young adulthood (20 to 31 years) and analyze lifestyle risk factors from adolescence (12 to 18 years). This analyze may define new CV risk factors and risk population cluster.

Conditions

  • Cardiovascular Risk Factor

Sponsors & Collaborators

  • University Hospital, Lille

    lead OTHER

Principal Investigators

  • Frédéric Gottrand, MD, PhD · University Hospital, Lille

Eligibility

Min Age
20 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-02-23
Primary Completion
2022-03-25
Completion
2022-03-25

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02899416 on ClinicalTrials.gov